Results 291 to 300 of about 483,373 (407)

Highly Conjugated Norditerpenoid and Pyrroloquinoline Alkaloids with Potent PTP1B Inhibitory Activity fromNigella glandulifera

, 2014
Qibin Chen, Xuelei Xin, Yi Yang, Shoei‐Sheng Lee, Haji Akber Aisa   +4 more
openalex   +1 more source

Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators.

Journal of the American Chemical Society, 2016
Andrew C. Kruegel, Madalee Gassaway, Abhijeet Kapoor, A. Váradi, S. Majumdar, M. Filizola, J. Javitch, D. Sames   +7 more
semanticscholar   +1 more source

Harnessing Natural Compounds in Psoriasis: Targeting Cellular Pathways for Effective Therapy

Phytotherapy Research, EarlyView.
Natural compounds act on key cellular pathways in psoriasis by suppressing keratinocyte hyperproliferation, modulating Th17/IL‐17‐mediated immune responses, and reducing oxidative stress. These multi‐target effects highlight their potential as safer adjunctive therapies alongside conventional treatments.
Hye Jin Lee, Yu Jin So, Il‐Joo Jo, Ji Yong Jang, Tae Han Yook, Jun Ho Lee, Sung Wook Kim, Kangwook Lee, Soo Jung Park, Gabsik Yang   +9 more
wiley   +1 more source

Three New Aporphine Alkaloids with Glucose Consumption Increase Activity from <i>Cassytha filiformis</i>. [PDF]

Molecules
Zhang C, Lin Y, Xie L, Wang Y, Xie Z, Dong L, Fu Y.   +6 more
europepmc   +1 more source

Harnessing cheminformatics for catalyst design I. Investigation into a general, asymmetric synthesis of cinchona alkaloid analogs towards asymmetric phase transfer II. Development of an enantioselective brønsted acid catalyzed four-component Ugi reaction

, 2017
Rebecca Marie Leising
openalex   +1 more source

Box–Behnken experimental design for extraction optimization of alkaloids from Erythrina verna Vell. trunk barks and LC Method Validation

, 2019
Douglas Fernando Rambo, Renata Biegelmeyer, Natally S.B. Toson, Roger R. Dresch, Paulo Roberto Hrihorowitsch Moreno, Amélia Teresinha Henriques   +5 more
openalex   +1 more source

Ashwagandha: Is It Safe? Part 2: A Preclinical Evidence Review

Phytotherapy Research, EarlyView.
ABSTRACT The preclinical evidence for the safety of ashwagandha (Withania somnifera (L.) Dunal, AS) is reviewed, and its preparations (extracts) and constituents, from the general toxicity in animal models to in vitro and cell culture studies, which may elucidate mechanisms of action and explain clinical case reports.
Elizabeth M. Williamson, Thomas Brendler
wiley   +1 more source

Metabolic profiling and pharmacological evaluation of alkaloids in three <i>Murraya</i> species. [PDF]

Front Plant Sci
Huang H, Geng X, Wang L, Wang X, Liu F, Peng Y, Tang C, Chen R, Liu Q.   +8 more
europepmc   +1 more source

Synthesis of the tricyclic indole alkaloids, dilemmaones A and B

, 2019
Katharine E. Lambson, Christopher A. Dacko, Jeffrey M. McNeill, Novruz G. Akhmedov, Björn C.G. Söderberg   +4 more
openalex   +2 more sources

Safety of 12‐Months Administration of Ashwagandha (Withania somnifera) Standardized Root Extract in Healthy Adults: A Prospective, Observational Study

Phytotherapy Research, EarlyView.
ABSTRACT Ashwagandha, an adaptogen, is an important herb of Ayurveda used as a Rasayana for its various health benefits. This prospective, multi‐center, observational clinical study evaluates the safety (clinical and laboratory) of a standardized Ashwagandha Root Extract (ARE) on long‐term administration over 12 months. Male and female adults (N = 191)
Jaising Salve, Sanjeev Kale, Banwari Lal Prajapati, Adele Sparavigna, Mark Savant, John Ademola, Deepak Langade   +6 more
wiley   +1 more source